Day: June 20, 2023

SANTA CLARA, Calif., June 20, 2023 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced the publication of its latest Sustainability Report, detailing its ESG (environmental, social and governance) initiatives and results over the past year. The report highlights the impact of the company’s ESG efforts within its own organization, with its suppliers and customers and on the global electronics ecosystem. “Applied Materials is at the forefront of semiconductor technologies that play an ever-increasing role in our lives,” said Gary Dickerson, President and CEO of Applied Materials. “As we bring transformative new innovations to market, we are working closely with our suppliers and customers to minimize our environmental impact by reducing our products’ resource consumption and carbon emissions. We are also continuing our strong...

PURCHASE, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”), announced today that Lisa Ricciardi, president and chief executive officer will participate on a panel during Cantor Fitzgerald’s virtual Brain Week 2023 conference, which will be held June 20-23, 2023. The panel of business and scientific experts from neuroscience-focused biotechnology companies will discuss emerging targets and differentiated strategies aimed at addressing the complex mechanisms that drive Alzheimer’s disease. Details of the panel are as follows: Title: Alzheimer’s Disease; Emerging Targets with Differentiated StrategiesDate and Time: June 23 at 10:30 a.m. ET About Cognition Therapeutics, Inc.Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery...

Drillhole Location Map at Woodlong Drillhole Location Map at WoodlongWoodlong Laterite Assays by Sc ppm (other figure intercept length) Woodlong Laterite Assays by Sc ppm (other figure intercept length)Highlights:Scandium enriched laterite formation defined at Woodlong prospect within the Honeybugle Exploration Licence 7977 area, where 32 vertical air core holes were drilled during first quarter 2023 in an approximately 300m x 400m area. Notable laterite intercepts:28 meters of 320 ppm Sc starting at 1m (EHAC-080) 21 meters of 355 ppm Sc starting at 1m (EHAC-083) 17 meters of 454 ppm Sc starting at 1m (EHAC-084) 9 meters of 569 ppm Sc starting at 2m (EHAC-087) 11 meters of 632 ppm Sc starting at 1m (EHAC-090) 10 meters of 537 ppm Sc starting at 1m (EHAC-092) 13 meters of 500 ppm Sc starting at 2m (EHAC-094) 13 meters of 517 ppm...

C3187C — Jun 20 2023 — ST_Airbus power-electronics collaboration_IMAGE FOR PRINT ST Airbus power-electronics collaborationAirbus and STMicroelectronics collaborate on power electronics for aircraft electrificationR&D collaboration on advanced power semiconductors, which are a key enabler of the aerospace industry’s transition to hybrid and full-electric systems     These semiconductors will play a significant role in powering future hybrid helicopters, aircraft, the ZEROe roadmap, as well as the City Airbus NextGenToulouse, France, and Geneva, Switzerland, June 20, 2023 — Airbus, a global pioneer in the aerospace industry, and STMicroelectronics (NYSE:STM), a global semiconductor leader serving customers across the spectrum of electronics applications, have signed an agreement to cooperate on power electronics...

CINCINNATI, June 20, 2023 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce that it has received final approval to list its common shares on the Toronto Stock Exchange (the “TSX”) and will commence trading on the TSX at market open on June 21, 2023 under the symbol “QIPT”. Concurrent with the commencement of trading on the TSX, the common shares will be delisted and will cease trading on the TSX Venture Exchange. “We are incredibly proud to announce the commencement of trading on the Toronto Stock Exchange. This significant milestone underscores our commitment to growth and provides a strong foundation for our investors. As we work to establish ourselves as a national leader...

AI-based PERSONA, with advanced facial recognition technology, bridges the gap between driver and vehicle by personalizing the overall vehicle experienceMullen Campus1 EV Cargo Van, Mullen FIVE and Bollinger B1 SUV PERSONA technology to be expanded across all Mullen commercial and consumer vehicles.PERSONA Offers Advanced Facial Recognition PERSONA starts to work the moment the driver walks up to their Mullen FIVE.BREA, Calif., June 20, 2023 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, today announces the integration of AI-powered PERSONA vehicle technology into its overall commercial and consumer vehicle lineups.  PERSONA, originally developed for the Mullen FIVE, is an advanced interactive AI camera/sensor and video...

NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) disorders, today announced that Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, will participate in a fireside chat at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference taking place on June 26, 2023. The fireside chat will be available on demand beginning on Monday, June 26, 2023, at 7:00 a.m. ET. Investors can register for the conference here. About Anavex Life Sciences Corp. Anavex Life Sciences Corp. (Nasdaq: AVXL)...

PHILADELPHIA, June 20, 2023 (GLOBE NEWSWIRE) — Republic First Bancorp, Inc. (NASDAQ: FRBK) (the “Company”), the parent company of Republic First Bank d/b/a Republic Bank (the “Bank”), today announced the appointment of Brian F. Doran, Esq., as Executive Vice President and General Counsel, effective June 20, 2023. Mr. Doran has a distinguished background in the financial services industry that includes relevant legal and corporate governance roles at top institutions. He will report to Thomas X. Geisel, President and CEO. In his new role at Republic, Mr. Doran will lead legal and corporate governance initiatives while providing operational and strategic support to the organization. He will also oversee areas that include litigation matters, insurance, and policy and procedure development.  Mr. Geisel commented: “We...

– Treatment with infigratinib at the Cohort 5 dose level resulted in a significant and robust increase in annual height velocity (AHV), with a mean change of +3.38 cm/year from baseline – 83% of children in Cohort 5 responded to infigratinib, as defined by an increase from baseline AHV of at least 25%. The mean change from baseline in AHV of responders was +4.08 cm/year – Early but promising trends towards improvement in proportionality were observed, as measured by the upper and lower body segment ratio – At six months, infigratinib was well-tolerated as a single daily oral therapy with no adverse events (AEs) assessed as treatment-related in all patients in Cohort 5 – Based on the positive Phase 2 results, BridgeBio is currently enrolling children for a pivotal Phase 3 trial PALO ALTO, Calif., June 20,...

‘Multi-Center Clinical Trial Using a Novel Semi-Quantitative Multiplex-PCR Based Diagnostic Panel for Urinary Tract Specimens’ presented on June 17th, 2023 Presentation focused on primary study endpoint and recommendations for result evaluation De Novo request for Unyvero Urinary Tract Infection (UTI) currently under Substantive Review by the FDA Additionally, data presented at the conference on Unyvero Implant and Tissue Infection (ITI) study from the University of CincinnatiROCKVILLE, Md., June 20, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported that its Principal Scientist Dr. Matthias Klein has presented results from the clinical trial for its Unyvero Urinary...